Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements

Nephrology Dialysis Transplantation

Volumn 20, Issue 8, 2005, Pages 1598-1603

  Gulati, Sanjeev ^a   Sharma, Raj K ^a   Gulati, Kiran ^a   Singh, Uttam ^b   Srivastava, Arvind ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bone mineral density; Calcium; Metabolic bone disease; Nephrotic syndrome; Prednisone; Vitamin D

Indexed keywords

CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; PREDNISONE; STEROID; VITAMIN D;

ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; CALCIUM INTAKE; CONTROLLED STUDY; DETERIORATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANTI-INFLAMMATORY AGENTS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NEPHROTIC SYNDROME; PREDNISONE; PROSPECTIVE STUDIES; VITAMIN D;

EID: 26444540414     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh809     Document Type: Article

References (19)

1. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 2003; 41: 1163-1169
2. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high dose glucocorticoid and one cycle etidronate therapy. Calcif Tissue Int 2000; 66: 195-199
3. Olgaard K, Storm T, Van Wovern N et al. Glucorticoid induced osteoporosis in lumbar spine, forearm and mandible of nephrotic patients:a double blind study on high dose long term effects of prednisolone versus deflazocort. Calcif Tissue Int 1992; 50: 460-467
4. Lettgen G, Jeken C, Reiners C. Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 1994; 8: 667-670
5. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 2004; 351: 868-875
6. Jehle PM, Jehle DR. Use of corticosteroids in nephrology - risk and prevention of osteoporosis induction. Nephrol Dial Transplant 2000; 15: 565-568
7. Talalaj M, Gradowska L, Marcinowska Suchowierska E, Durlik M, Gaciong Z, Lao M. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant Proc 1996; 28: 3485-3487
8. Gulati S, Kher V, Sharma RK, Gupta A. Steroid response pattern in Indian children with nephrotic syndrome. Acta Pediatr Scand 1994; 83: 530-533
9. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin N Eng J Med 1993; 328: 1747-1752
10. ISCD Position Development Conference. J Clin Densitom 2002; 7: 17-26
11. Cunnane G, Lane NE. Steroid induced osteoporosis in systemic lupus erythematosus. Rheum Dis North Am 2000; 26: 311-329
12. Pitt P, Todd P, Webber D, Pack S, Moniz C. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment. Thorax 1998; 53: 351-356
13. Sambrook PN. Inhaled corticosteroids, bone density and risk of fracture. Lancet 2000; 355: 9213
14. Van Staa TP, Cooper C, Leufkens HGM, Bishop N. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003; 18: 913-918
15. Buckley LM, Leib ES, Cartularo KS et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996; 125: 961-968
16. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-282
17. Goulding A, Canna R, Willimas SM, Gold EJ, Taylor RW, Lewis-Barned NJ. Bone mineral density in girls with forearm fractures. J Bone Miner Res 1998; 13: 143-148
18. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol 2000; 42: 403-405
19. Mehls O. Is it correct to supplement patients with nephrotic syndrome with vitamin D and calcium? Pediatr Nephrol 1990; 4: 519